TL;DR
This study reveals that two RNA-binding proteins, RBPMS and RBPMS2, work together to ensure proper splicing of genes critical for heart development and function. When both are absent, embryos die early with severe heart defects, highlighting their essential cooperative role in maintaining the heart's unique "splicing signature."
What Problem Does This Paper Address?
The heart's complex proteome relies heavily on alternative splicing, a process finely tuned by splicing factors (SFs). While mutations in SFs are known to cause heart disease, the specific functional importance of collaboration between cardiac SFs has remained largely unknown. This paper investigates how two related SFs, RBPMS and RBPMS2, which are both present in heart cells and show similar in vitro activity, cooperate in vivo to regulate cardiac gene splicing and heart development.
Methods
The researchers generated genetically modified mice lacking either RBPMS or RBPMS2, or both, specifically in cardiomyocytes (heart muscle cells). They analyzed these mice for cardiac phenotypes, including survival, heart structure, and function, using techniques like echocardiography and histology. To understand the molecular mechanisms, they performed RNA sequencing (RNA-seq) to identify changes in gene expression and alternative splicing. They also used computational tools to map where RBPMS and RBPMS2 bind to RNA and to analyze the characteristics of the affected splicing events.
Datasets
The study utilized RNA-seq data from various wild-type mouse tissues at different developmental stages (embryonic, neonatal, adult) to establish baseline "cardiac splicing signatures." This data was compared with RNA-seq data from the generated knockout mouse models.
Key Insights and Ideas
- Essential Partnership: RBPMS and RBPMS2 aren't just redundant; they are essential partners. While single knockouts have milder issues, losing both leads to embryonic lethality, proving their cooperative role is vital.
- "Cardiac Splicing Signature": The heart has a unique pattern of RNA splicing. RBPMS and RBPMS2 are crucial for maintaining this signature, preventing it from shifting towards non-cardiac tissue patterns.
- "Positional Effects" in Splicing: Where RBPMS and RBPMS2 bind on a gene's precursor RNA dictates whether they act as splicing activators (promoting inclusion of a segment) or repressors (promoting skipping).
- Intrinsic Exon Features Matter: The specific characteristics of a gene's exon (like the strength of its splice sites) determine if one or both RBPMS proteins are needed for proper splicing.
Key Results
- Mice lacking both RBPMS and RBPMS2 in cardiomyocytes died before embryonic day 13.5 and showed severe sarcomere disarray.
- Mice lacking only RBPMS or only RBPMS2 in cardiomyocytes survived to adulthood but displayed distinct cardiac defects (e.g., noncompaction cardiomyopathy for RBPMS loss).
- RNA-seq revealed that RBPMS and RBPMS2 collectively regulate the splicing of sarcomere and other cardiac contraction-related genes.
- The splicing profile of double knockout hearts shifted significantly towards non-cardiac tissue patterns, while single knockouts largely retained a cardiac profile.
- RNA mapping showed that RBPMS and RBPMS2 bind to specific DNA motifs (CAC) and their binding location influences their regulatory role.
Limitations and Future Work
The study acknowledges that all tested RBPMS and RBPMS2 antibodies recognized both proteins, limiting their ability to distinguish individual protein localization via immunofluorescence. Future work could explore the formation of RBPMS-RBPMS2 hetero-oligomers and how disrupting this interaction affects splicing regulation. Additionally, understanding the precise expression patterns of RBPMS and RBPMS2 in different heart cell types would be valuable.
Summary updated